title: [Two-years follow-up of radiofrequency thermotherapy for urination disorders due to benign prostatic hyperplasia].
abstract: OBJECTIVE
  To describe medium-term functional results of Transurethral Needle Ablation (TUNA) to treat symptomatic benign prostatic hyperplasia (BPH) refractory to medical treatment.
  
  
  METHODS
  Patients who completed at least 2 years follow-up after TUNA were systematically offered a reevaluation including: Flowmetry, PSA, symptom score (IPSS), satisfaction index visual analogic scale (VAS) and a treatment impact evaluation with a Likert scale (ranging from much worse to much improved).
  
  
  RESULTS
  From December 2002 to January 2007, 45 patients were treated with TUNA under local regional anaesthesia (prostatic block). Twenty-seven of them were followed-up longer than 24 months (median follow-up 44 months [26-52]). Changes in the selected outcomes were: increase in Qmax from 9.5 mL/s preoperatively to 9 mL/s at 6 month and 11.5 mL/s after 2 years; increase in IPSS from 19.3 before TUNA to 16.3 at 6 month and 16.5 after 2 years. About subjective evaluation, 58% of patient gave a satisfaction VAS>or=6, and the improvement index was greater or equal to +1 in 67% of case.
  
  
  CONCLUSIONS
  In this initial monocentric experiment, despite a modest improvement of objective parameters and a 20% of retreatment rate, TUNA give contentment and improvement sensation for 60% of patients who were treated for non-efficiency of medical treatment for benign prostatic hyperplasia.
authors: Hôpital Sainte-Marguerite, 4, boulevard A.-Laveran, BP 50, 13998 Marseille Armées, France. phsavoie@hotmail.fr
authors: P-H
authors: PH
authors: Savoie
authors: L
authors: L
authors: Lopez
authors: O
authors: O
authors: Simonin
authors: M
authors: M
authors: Loubat
authors: F
authors: F
authors: Bladou
authors: G
authors: G
authors: Serment
authors: G
authors: G
authors: Karsenty
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D017115:Catheter Ablation; D053159:Dysuria / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000150:complications / Q000276:immunology / Q000601:surgery*; D011594:Psychometrics; D012189:Retrospective Studies; D012212:Rheology; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome; D016055:Urinary Retention / Q000601:surgery; D014555:Urination Disorders / Q000209:etiology / Q000601:surgery*
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen